Healthcare Sector

IVVD

Market Tracker

  • IVVD (Selected)

    Adagio Therapeutics, Inc.

IVVD Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

IVVD Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

IVVD Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

IVVD Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/17/2025 CALL $2.50 106 +5 +4.95%
12/20/2024 CALL $2.50 272 0
12/20/2024 CALL $5.00 63 0
12/20/2024 CALL $7.50 22 0
12/20/2024 PUT $2.50 48 0
12/20/2024 PUT $5.00 0 0
06/20/2025 CALL $5.00 0 0
06/20/2025 CALL $7.50 1 0
06/20/2025 PUT $2.50 20 0
06/20/2025 PUT $5.00 0 0
06/20/2025 PUT $7.50 0 0
03/21/2025 CALL $2.50 1,161 -2 -0.17%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

IVVD Major Holders

Name Pct Held Shares Total
Fidelity Growth Company Fund 4.35% 4.76M 5.99M
Fidelity Series Growth Company Fund 1.52% 1.66M 2.1M
Vanguard Total Stock Market Index Fund 1.48% 1.62M 2.04M
iShares Russell 2000 ETF 1.02% 1.11M 1.4M
Fidelity Growth Company K6 Fund 0.82% 892.97k 1.13M
Vanguard Extended Market Index Fund 0.68% 747.48k 941.82k
iShares Russell 2000 Value ETF 0.47% 512.72k 646.02k
Fidelity Small Cap Index Fund 0.40% 440.43k 554.94k
iShares NASDAQ Biotechnology ETF 0.27% 289.73k 365.06k
Price (T.Rowe) Health Sciences Fund 0.26% 288.95k 364.08k

IVVD News

  • Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference

    11/06 09:01 am

    GlobeNewswire Inc.

    Read more
  • Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024

    11/06 08:01 am

    GlobeNewswire Inc.

    Read more
  • Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024

    10/16 07:01 am

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes

    07/01 07:01 am

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants

    06/14 07:01 am

    GlobeNewswire Inc.

    Read more
  • Invivyd to Participate at the Jefferies Global Healthcare Conference

    06/03 04:01 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial Monoclonal Antibodies

    05/31 07:05 am

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer

    05/31 07:00 am

    GlobeNewswire Inc.

    Read more
  • Invivyd Elects Two New Independent Members to its Board of Directors

    05/22 07:00 am

    GlobeNewswire Inc.

    Read more
  • Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

    05/13 04:01 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights

    05/09 04:01 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback

    05/07 07:30 am

    GlobeNewswire Inc.

    Read more
  • Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights

    05/02 05:13 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position

    04/30 07:30 am

    GlobeNewswire Inc.

    Read more
  • Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™

    04/15 07:30 am

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces CEO Transition

    04/12 07:30 am

    GlobeNewswire Inc.

    Read more
  • Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session

    04/05 08:01 am

    Benzinga

    Read more
  • Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million

    04/04 04:01 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights

    03/28 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    03/26 01:45 pm

    Benzinga

    Read more
  • Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday

    03/26 10:36 am

    Benzinga

    Read more
  • Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket

    03/26 08:00 am

    Benzinga

    Read more
  • Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    03/25 02:44 pm

    Benzinga

    Read more
  • Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday

    03/25 10:32 am

    Benzinga

    Read more
  • Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket

    03/25 08:03 am

    Benzinga

    Read more
  • Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial

    03/22 03:28 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19

    03/22 03:04 pm

    GlobeNewswire Inc.

    Read more
  • Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    02/12 02:07 pm

    Benzinga

    Read more
  • Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

    02/05 05:02 pm

    GlobeNewswire Inc.

    Read more
  • Apple To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday

    01/18 08:50 am

    Benzinga

    Read more
  • All You Need to Know About Invivyd, Inc. (IVVD) Rating Upgrade to Strong Buy

    01/12 01:00 pm

    Zacks Investment Research

    Read more
  • Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?

    12/23 06:29 am

    The Motley Fool

    Read more
  • Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    12/19 02:34 pm

    Benzinga

    Read more
  • Invivyd (IVVD) Surges on Positive Data From COVID-19 Study

    12/19 12:52 pm

    Zacks Investment Research

    Read more
  • Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday

    12/19 11:19 am

    Benzinga

    Read more
  • Nasdaq Gains 100 Points; Biomerica Shares Spike Higher

    12/18 03:21 pm

    Benzinga

    Read more
  • Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    12/18 02:05 pm

    Benzinga

    Read more
  • Crude Oil Rises 3%; US Housing Market Index Increases In December

    12/18 01:17 pm

    Benzinga

    Read more
  • Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19

    12/18 08:00 am

    GlobeNewswire Inc.

    Read more
  • Invivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results and Business Highlights

    11/02 04:01 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd to Participate in Upcoming Investor Conferences

    10/31 04:01 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 

    09/11 07:00 am

    GlobeNewswire Inc.

    Read more
  • Invivyd (IVVD) Stock Rises 18% in 3 Months: Here's Why

    08/29 01:13 pm

    Zacks Investment Research

    Read more
  • Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights

    08/10 04:01 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd to Host Conference Call Discussing Second Quarter 2023 Financial Results and Business Highlights

    08/03 04:01 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces Appointment of Sara Cotter to Board Of Directors

    07/27 04:01 pm

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces General Alignment with FDA on Pathway to Potential EUA for VYD222 and Anticipated Follow-On Monoclonal Antibody Candidates Designed to Prevent COVID-19

    06/26 07:00 am

    GlobeNewswire Inc.

    Read more
  • Invivyd Announces Positive Initial Data from Ongoing Phase 1 Clinical Trial of VYD222, a Monoclonal Antibody Candidate in Development for the Prevention of Symptomatic COVID-19 in Immunocompromised People

    06/22 07:00 am

    GlobeNewswire Inc.

    Read more
  • Invivyd to Participate at the Jefferies Healthcare Conference

    06/01 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    05/31 01:01 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: